Tempace
- 14691-89-5
- 4-Acetamido-2,2,6,6-tetramethylpiperidine 1-oxyl
- Tempace
- 4-Acetamido-TEMPO, free radical
- G7ABJ73L6S
- Create:2005-03-27
- Modify:2025-01-11
- 14691-89-5
- 4-Acetamido-2,2,6,6-tetramethylpiperidine 1-oxyl
- Tempace
- 4-Acetamido-TEMPO, free radical
- G7ABJ73L6S
- 4-acetylamino-tempo
- UNII-G7ABJ73L6S
- 4-N-ACETYLAMINO-TEMPO
- CHEBI:180673
- 4-acetamido-2,2,6,6-tetramethylpiperidine-1-oxyl
- 4-Acetamido-2,2,6,6-tetramethylpiperidinyloxy
- EC 423-840-3
- 4-Acetamido-2,2,6,6-tetramethylpiperidinyloxyl
- 1-oxyl-2,2,6,6-tetramethyl-4-acetamidopiperidine
- 2,2,6,6-Tetramethyl-4-acetamidopiperidine-1-oxyl
- 4-Acetamido-2,2,6,6-tetramethylpiperidino-1-oxyl
- 4-acetamino-2,2,6,6-tetramethylpiperidine-1-oxyl
- N-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)acetamide
- (4-Acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl
- 2,2,6,6-TETRAMETHYL-4-ACETAMIDOPIPERIDIN-1-OXYL
- PIPERIDINOOXY, 4-ACETAMIDO-2,2,6,6-TETRAMETHYL-
- 4-ACETAMIDE-2,2,6,6-TETRAMETHYL-1-PIPERIDIN-YLOXY
- acetamide-TEMPO
- 4-Acetamido-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical [Catalyst for Oxidation]
- 4-acetamide-TEMPO
- MFCD00043593
- AKOS015910523
- 4-Acetamido-TEMPO, free radical, 97%
- AS-17419
- CS-0188148
- 4-acetamido-2,2,6,6-tetramethylpiperidinooxy
- 4-acetamido-2,2,6,6-tetramethylpiperidin-1-oxy
- 4-Acetamido-2,2,6,6-tetramethylpiperidine1-oxyl
- 2,2,6,6-tetramethyl-4-acetylaminopiperidin-1-oxyl
- 4-acetamido-1-oxyl-2,2,6,6-tetramethylpiperidine
- 4-acetamido-2,2,6,6-tetramethyl-1-piperidinyloxy
- 4-acetylamino-2,2,6,6-tetramethylpiperidine N-oxyl
- W-201301
- 4-(acetylamino)-2,2,6,6-tetramethylpiperidin-1-oxyl
- 4-(acetylamino)-2,2,6,6-tetramethylpiperidin-1-yloxyl
- (4-acetamido-2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl
- 4-Acetamido-2,2,6,6-tetramethylpiperidine 1-oxyl, purum, >=98.0% (HPLC)
H302 (96.6%): Harmful if swallowed [Warning Acute toxicity, oral]
H319 (29.3%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 116 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Acute Tox. 4 (96.6%)
Eye Irrit. 2 (29.3%)
Status: Cease Manufacture Update: 10-11-2008 https://echa.europa.eu/registration-dossier/-/registered-dossier/8967
Status: Active Update: 19-12-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/34355
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=UXBLSWOMIHTQPH-UHFFFAOYSA-N
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/4-Acetamido-TEMPOhttps://commonchemistry.cas.org/detail?cas_rn=14691-89-5
- ChemIDplusChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- EPA Chemicals under the TSCA1-Piperidinyloxy, 4-(acetylamino)-2,2,6,6-tetramethyl-https://www.epa.gov/chemicals-under-tscaEPA TSCA Classificationhttps://www.epa.gov/tsca-inventory
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-notice[4-(acetylamino)-2,2,6,6-tetramethylpiperidin-1-yl]oxidanylhttps://chem.echa.europa.eu/100.102.2391-Piperidinyloxy, 4-(acetylamino)-2,2,6,6-tetramethyl-https://echa.europa.eu/substance-information/-/substanceinfo/100.117.843[4-(acetylamino)-2,2,6,6-tetramethylpiperidin-1-yl]oxidanyl (EC: 423-840-3)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/538791-Piperidinyloxy, 4-(acetylamino)-2,2,6,6-tetramethyl- (EC: 604-549-2)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/57476
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking4-ACETAMIDO-TEMPOhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/G7ABJ73L6S
- New Zealand Environmental Protection Authority (EPA)LICENSEThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.https://www.epa.govt.nz/about-this-site/general-copyright-statement/
- ChEBI4-acetamido-TEMPOhttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:180673
- Hazardous Chemical Information System (HCIS), Safe Work Australia
- Regulation (EC) No 1272/2008 of the European Parliament and of the CouncilLICENSEThe copyright for the editorial content of this source, the summaries of EU legislation and the consolidated texts, which is owned by the EU, is licensed under the Creative Commons Attribution 4.0 International licence.https://eur-lex.europa.eu/content/legal-notice/legal-notice.htmlN-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;...https://eur-lex.europa.eu/eli/reg/2008/1272/oj
- Japan Chemical Substance Dictionary (Nikkaji)
- SpectraBase4-ACETAMIDO-2,2,6,6-TETRAMETHYLPIPERIDINOOXY (FREE RADICAL)https://spectrabase.com/spectrum/JENXbrtZ4JQ4-Acetamido-TEMPO, free radicalhttps://spectrabase.com/spectrum/Gi2sd6FmFOn4-Acetamido-TEMPO, free radicalhttps://spectrabase.com/spectrum/B0zoLHwxbU84-Acetamido-TEMPO, free radicalhttps://spectrabase.com/spectrum/5q6kVHbe6tY4-Acetamido-TEMPO, free radicalhttps://spectrabase.com/spectrum/B9MK9nUUjK24-Acetamido-2,2,6,6-tetramethylpiperidinyloxyhttps://spectrabase.com/spectrum/eXEz2gB3Re
- The Cambridge Structural Database
- Thieme ChemistryLICENSEThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc-nd/4.0/
- Wikidata4-acetamido-TEMPOhttps://www.wikidata.org/wiki/Q27278880
- Wiley
- PubChem
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.html
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 389417902https://pubchem.ncbi.nlm.nih.gov/substance/389417902